Using special foam to stop severe bleeding in traumatic injuries
Official title: Shape Memory Polymer Foams for Hemorrhage Control in Traumatic Wounds
Funded at Syracuse University · NIH-11093441 · Data updated 2026-11-12
This study is testing a new foam that can help stop bleeding from serious injuries, making it easier for anyone to use in emergencies, especially in places far from hospitals.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Syracuse University NIH-funded |
| Lab location | 1 site (Syracuse, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $525,733 |
| NIH project number | 5R01HL168180-03 |
| Project ID | NIH-11093441 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced traumatic injuries that result in severe bleeding.
✕Less likely to help
Patients with non-traumatic conditions or those who do not experience significant hemorrhage may not benefit from this research.
What this research studies
This research focuses on developing a new type of foam made from shape memory polymers that can effectively control bleeding in traumatic wounds. The approach involves testing this foam in models that simulate real-life injuries to determine how well it can stop hemorrhaging. The goal is to create a product that is easy to use, requires minimal training, and can be applied in emergency situations, especially in remote areas. By improving the materials used for hemorrhage control, the research aims to reduce deaths caused by uncontrolled bleeding before patients reach medical facilities.
Why it matters
Potential benefit: If successful, this research could provide a life-saving tool for managing severe bleeding in trauma patients.
How similar studies have gone: Preliminary studies have shown promising results with similar materials, indicating potential for success in this novel approach.
Where this research is happening
-
Syracuse University
Syracuse, United States Active
Researchers
- Principal investigator: Monroe, Mary Beth — Syracuse University
- Study coordinator: Monroe, Mary Beth
Related research
Other NIH-funded projects on the same topics.
-
Wearable tech to track blood loss during childbirth
A wearable device monitors cardiovascular signals to detect postpartum hemorrhage early so clinicians can act quickly to protect mothers.
-
SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers
This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.
-
Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study
This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.
-
Statin use after brain bleed: SATURN MRI ancillary study
This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.
-
Maternal Postpartum Monitoring with a Wearable Sensor (MOMS)
A wearable system called MOMS will continuously monitor multiple physiological signals in pregnant people to detect postpartum hemorrhage earlier than standard vital signs.
-
Anticoagulation in ICH Survivors with Atrial Fibrillation and Small Vessel Disease
This project looks at how to safely use blood-thinning medicines in people who survived a brain bleed and also have atrial fibrillation and small vessel disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.